MiR-127 modulates macrophage polarization and promotes lung inflammation and injury by activating the JNK pathway

Hangjie Ying1, Yanhua Kang1, Hang Zhang1

  • 1Department of Basic Medical Science, Key Laboratory of Immunology and Molecular Medicine, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 310036, China;

Insights

MicroRNA-127 (miR-127) drives inflammation and lung injury by promoting proinflammatory macrophages. Inhibiting miR-127 reduces inflammation, suggesting it as a therapeutic target for inflammatory diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Macrophage polarization is crucial in immunological diseases, but the mechanisms controlling their function are unclear.
  • Understanding macrophage functional shaping is key to addressing inflammatory pathologies.

Purpose of the Study:

  • To elucidate the role of microRNA-127 (miR-127) in macrophage development and its impact on inflammation and lung injury.
  • To identify miR-127 as a potential therapeutic target for inflammatory conditions.

Main Methods:

  • Investigated miR-127 induction upon Toll-like receptor (TLR) engagement and repression by M2-prone cytokines.
  • Utilized enforced expression and deletion of miR-127 in macrophages.
  • Administered miR-127 intratracheally in a mouse model.
  • Performed mechanistic studies involving B cell lymphoma 6 (Bcl6), dual specificity phosphatase 1 (Dusp1), and JNK kinase signaling.

Main Results:

  • miR-127 is induced by TLRs and repressed by M2 cytokines, promoting proinflammatory cytokine production.
  • miR-127 deletion leads to M2-biased responses and impaired M1 gene expression.
  • Intratracheal miR-127 exacerbates pulmonary inflammation and injury; its antagonism confers protection.
  • Mechanistically, miR-127 targets Bcl6, downregulating Dusp1 and activating JNK, promoting M1 macrophage development.

Conclusions:

  • miR-127 acts as a molecular switch in macrophage development, driving M1 polarization and inflammatory responses.
  • Targeting miR-127 offers a potential therapeutic strategy for treating inflammatory diseases like lung injury.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K